We investigated delayed-type hypersensitivity to human papillomavirus (HPV)
in women with cervical dysplasia or cancer, Women were challenged by skin
tests with synthetic HPV-16 E7 oncoprotein peptides. 11 women were regresso
rs (cleared disease without treatment) and 37 were progressors (required su
rgery). Antibodies to early antigens (markers for progression) were detecta
ble in a higher proportion of cancer patients than all other patients, part
icularly progressors with cervical intraepithelial neoplasia (CIN). By cont
rast, cellular immunity to HPV-16 E7, measured by skin test. was significan
tly (p=0.0001) associated with clinical and cytological resolution of HPV-i
nduced GIN, indicating that E7-specific T-helper cells have a role in contr
ol of HPV.